17p Allelic Losses in Diploid Cells of Patients with Barrett's Esophagus Who Develop Aneuploidy

Patricia L. Blount, Patricia C. Galipeau, Carissa A. Sanchez, Katayoun Neshat, Douglas S. Levine, Jing Yin, Hiroyuki Suzuki, John M. Abraham, Stephen J. Meitzer, Brian J. Reid

Research output: Contribution to journalArticle

Abstract

Inactivation of the p53 gene, located on chromosome 17p, leads to genetic instability and aneuploidy in vitro. Aneuploid cell populations from Barrett's adenocarcinomas have a high prevalence of 17p allelic losses, and there is substantial evidence that the target of these losses is the p53 gene. If 17p allelic losses lead to aneuploidy in Barrett's esophagus, then they should be present in diploid cells from patients who develop aneuploidy. We detected 17p allelic losses in diploid cells from 10 of 11 patients (91%) with Barrett's esophagus who developed aneuploid cell populations. Our data strongly suggest that 17p allelic losses precede the development of aneuploidy during neoplastic progression in Barrett's esophagus in vivo and, therefore, support in vitro evidence for the role of p53 in genetic instability.

Original languageEnglish (US)
Pages (from-to)2292-2295
Number of pages4
JournalCancer Research
Volume54
Issue number9
StatePublished - May 1994
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of '17p Allelic Losses in Diploid Cells of Patients with Barrett's Esophagus Who Develop Aneuploidy'. Together they form a unique fingerprint.

  • Cite this

    Blount, P. L., Galipeau, P. C., Sanchez, C. A., Neshat, K., Levine, D. S., Yin, J., Suzuki, H., Abraham, J. M., Meitzer, S. J., & Reid, B. J. (1994). 17p Allelic Losses in Diploid Cells of Patients with Barrett's Esophagus Who Develop Aneuploidy. Cancer Research, 54(9), 2292-2295.